MedTrace Logo

New Hydroxyethyl Cellulose Hydrogel for the Treatment of the Pain of Knee Arthrosis

NCT04061733 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 50

Last updated 2022-12-29

No results posted yet for this study

Summary

Prospective, multicenter study, unmasked, single-arm, to study the safety and efficacy of a new hydroxyethyl cellulose hydrogel for the treatment of the knee pain caused by osteoarthritis.

Conditions

  • Osteoarthritis, Knee
  • Pain

Interventions

DEVICE

Hydrogel injection

Hydrogel injection

Sponsors & Collaborators

  • Promedon

    lead INDUSTRY

Principal Investigators

  • Fernando E. Barclay, Dr. · IADT

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
40 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-09-30
Primary Completion
2023-07-31
Completion
2024-07-31

Countries

  • Argentina

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04061733 on ClinicalTrials.gov